GLOBAL DIMENSIONAL COMPLEXITY OF THE EEG IN HEALTHY-VOLUNTEERS

被引:20
|
作者
MATOUSEK, M [1 ]
WACKERMANN, J [1 ]
PALUS, M [1 ]
BERANKOVA, A [1 ]
ALBRECHT, V [1 ]
DVORAK, I [1 ]
机构
[1] PRAGUE PSYCHIAT CTR,PRAGUE,CZECH REPUBLIC
关键词
EEG CORRELATION DIMENSION; EEG GLOBAL DIMENSIONAL COMPLEXITY; NONLINEAR METHODS; ALERTNESS LEVEL; AGE;
D O I
10.1159/000119171
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In contrast to the single-channel dimensional complexity, the global dimensional complexity is calculated from a multichannel EEG. The intention with the method is to measure the spatial distribution of information processing in the brain. The method seems to be of interest in psychopharmacological research, but the interpretation of the results in physiological terms is rather difficult. To get a more detailed information on the physiological significance of the EEG complexity measures, the influence of well-known physiological factors was studied in a group of 14 healthy subjects aged from 1.5 to 61 years. It was found that the correlation dimension was somewhat higher in older individuals, but the correlation with age was not statistically significant. However, the global correlation dimension was significantly lower during full alertness than during drowsiness. These results might reflect the changes in spatial structure of information processing, a high complexity suggesting a 'disorganisation' during drowsiness. As regards the age-dependent changes of the correlation dimension, the spatial 'flexibility' of information processing was also studied, using the differences between the 'alert' and 'drowsy' parts of the same EEG as indicator. It was found that the differences 'drowsy minus alert' were significantly related to age. A plausible interpretation seems to be that the spatial distribution of information processing is more changeable, or more flexible, in adults than in children.
引用
收藏
页码:47 / 52
页数:6
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF CISAPRIDE IN HEALTHY-VOLUNTEERS
    VANPEER, A
    WOESTENBORGHS, R
    VERLINDEN, M
    MEULDERMANS, W
    HEYKANTS, J
    DIGESTION, 1986, 34 (02) : 138 - 138
  • [42] HALOPERIDOL PHARMACOKINETICS IN HEALTHY-VOLUNTEERS
    KUNKA, RL
    STILLER, RL
    PEREL, JM
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S112 - S112
  • [43] HIV SCREENING IN HEALTHY-VOLUNTEERS
    HARRY, JD
    BABER, N
    POSNER, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 39 (02) : 213 - 214
  • [44] BIOAVAILABILITY OF NAFARELIN IN HEALTHY-VOLUNTEERS
    CHAPLIN, MD
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 166 (02) : 762 - 765
  • [45] RESEARCH ON HEALTHY-VOLUNTEERS - A REPORT
    不详
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1986, 20 (04): : 243 - 257
  • [46] THE PHARMACOKINETICS OF CHLOROQUINE IN HEALTHY-VOLUNTEERS
    WALKER, O
    ALVAN, G
    BEERMANN, B
    GUSTAFSSON, LL
    LINDSTROM, BL
    SJOQVIST, F
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (04) : P624 - P624
  • [47] PHENYTOIN BINDING IN HEALTHY-VOLUNTEERS
    BERG, MJ
    EBERT, BE
    FINCHAM, RW
    SCHOTTELIUS, DD
    THERAPEUTIC DRUG MONITORING, 1987, 9 (04) : 384 - 388
  • [48] PHARMACOKINETICS OF DEFIBROTIDE IN HEALTHY-VOLUNTEERS
    NOSEDA, G
    FRAGIACOMO, C
    FERRARI, D
    HAEMOSTASIS, 1986, 16 : 26 - 30
  • [49] HALOPERIDOL PHARMACOKINETICS IN HEALTHY-VOLUNTEERS
    KUNKA, RL
    PEREL, JM
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1989, 45 (06): : 1088 - 1096
  • [50] PHARMACOKINETICS OF ROXATIDINE IN HEALTHY-VOLUNTEERS
    COLLINS, JD
    PIDGEN, AW
    DRUGS, 1988, 35 : 41 - 47